Abstract Body

Background

Chronic immune activation related to cytomegalovirus (CMV) infection may contribute to multimorbidity in people with HIV. We examined associations between CMV IgG concentration and multimorbidity burden in people with HIV from the Pharmacokinetic and clinical Observations in PeoPle over fiftY (POPPY) study.

Methods

Five morbidity patterns (cardiovascular (CVD), Metabolic, Mental/Joint, Neurological, Cancer/Other) were identified at baseline using principal component analysis (PCA). For each category, participant burden z-scores were calculated from PCA loadings applied to the presence/absence of comorbidities within each pattern; scores >0 indicate higher burden relative to the cohort mean. Changes in scores were calculated between baseline and follow-up visit (approx. 2-3 years later). CMV IgG concentrations were measured on baseline plasma samples (DiaSorin LIAISON CMV IgG II assay). Associations between log-transformed CMV IgG concentration and morbidity z-scores were assessed among CMV-seropositive participants using linear regression, adjusted for age, sex, ethnicity, body mass index (BMI), smoking, alcohol use, recreational drug use, years since HIV diagnosis, CD4+ count, nadir CD4+ and prior AIDS diagnosis. 

Results

Analysis included 720 CMV-seropositive participants with HIV (median [interquartile range; IQR] age 53 [48-59] years; 87% male; 85% white). At baseline, the median [IQR] z-scores were metabolic: -0.30 (-0.89, 0.49); Mental/Joint -0.38 (-0.97, 0.68); Neurological -0.56 (-0.56, 0.32); Cancer/Other -0.62 (-0.62, 0.29) and CVD -0.62 (-0.62, 0.56). In unadjusted models, higher CMV IgG was associated with greater baseline burden across CVD, Metabolic, Mental/joint, and Cancer/Other categories. After adjustment, significant associations remained for Mental/Joint (β=0.10 [0.01,0.18], p=0.03) and Cancer/Other (β=0.12 [0.04,0.20], p=0.003) burden. Although higher CMV IgG concentrations were associated with a slight increase in CVD and Metabolic z-scores, these associations were no longer significant after adjustment. 

Conclusions

Among CMV-seropositive people with HIV, higher CMV IgG concentrations were associated with greater burden of mental/joint, and cancer-related multimorbidity. These findings suggest that CMV IgG could serve as a potential marker to identify subgroups at higher risk of multimorbidity who could benefit from targeted interventions. 

Table or Figure